Areximbank-Gazprombank Group successfully certified by ISO 9001: 2008

YEREVAN, February 8. /ARKA /. Areximbank-Gazprombank Group said it has been successfully certified in accordance with requirements of ISO 9001: 2008 standards. The certification was conducted by French auditing company AB Certification.

Areximbank-Gazprombank Group (formerly Areximbank) was established in 1998 to handle financial flows between Armenia and Russia. It is a principled member of VISA International and MasterCard International payment systems. In 2007 it joined Armenian ArCa payment system.

The bank is owned fully by Russian Gazprombank and has 6 branches in Yerevan and 9 in regions. As of January 1, 2011 its total capital stood at 14.9 billion Drams, the normative total capital at 20.3 billion Drams. Its assets were above 67.4 billion Drams and liabilities stood at 52.5 billion Drams. -0-

spot_img

POPULAR

Armenia set to enhance development of its capital market, targeting large issuers and new investors

YEREVAN, August 20. /ARKA/. The Armenian government prioritizes diversifying funding sources and advancing the capital market to foster sustainable and productive economic growth.

Armenian dram strengthens against US dollar and weakens against euro and ruble

YEREVAN, August 21. /ARKA/. The average market exchange rate of the US dollar to the Armenian dram on the Armenian foreign exchange market on August 21, 2026, fell by 0.1 point to 365.16 drams compared to August 20.

New requirements for banks to manage risks of circumventing international sanctions come into effect in Armenia

YEREVAN, August 17. /ARКА/. As of August 12, 2026, new regulations for banks regarding the management of risks associated with evading international sanctions have been implemented in Armenia.

“AGROVISION” CJSC’s bonds were listed on Armenia Stock Exchange

YEREVAN, August 17. /ARKA/.  Today, “AGROVISION” CJSC, a company operating in the agro-industrial sector, became a listed company on the Armenia Stock Exchange (AMX).

Shares of Noubar Afeyan’s Moderna soared 124% on news of a successful cancer vaccine trial

YEREVAN, August 20. /ARKA/. Shares of the biotech company Moderna soared 123.6% at the start of trading in the US on August 19, reaching a peak of $140.77, according to trading data. Shares of the pharmaceutical company Merck also rose 11.6% to $150.85, according to Forbes.ru.

LATEST NEWS

spot_imgspot_imgspot_img